甘草汤通过激活CaMKII减少海马β-淀粉样蛋白改善阿尔茨海默病
本研究探讨中药复方甘草汤(LC)改善阿尔茨海默病(AD)的作用及机制。在APP/PS1小鼠中,LC或多奈哌齐(DON)治疗14天可减轻Morris水迷宫和Y迷宫的行为缺陷,逆转海马CaMKII磷酸化及突触蛋白(synapsin1、PSD95)减少和Aβ面积增加;抑制CaMKII则阻断LC的疗效。结论提示LC通过激活CaMKII减少Aβ形成、增强海马神经元功能而缓解AD。
要点
- LC可改善APP/PS1小鼠空间记忆与学习缺陷。
- LC的作用与激活CaMKII、减少海马Aβ及提升突触蛋白相关。
- 抑制CaMKII可阻断LC对突触蛋白和神经发生的增强作用。
核心结论
- 甘草汤通过激活CaMKII减少Aβ形成,增强海马神经元功能,从而缓解AD。
研究设计与样本
- 采用APP/PS1 AD模型小鼠与C57BL6/J小鼠对照,LC或多奈哌齐(DON)慢性治疗14天。
- 用GC和HPLC-MS鉴定LC主要成分并检测提取稳定性,用Morris水迷宫和Y迷宫评估行为,用Western blot和免疫染色评估海马分子信号与神经发生,并用药理干预探索靶点关联。
主要发现
- APP/PS1小鼠在Morris水迷宫到达平台时间显著延长、在无平台区域停留时间减少,Y迷宫探索新臂潜伏期延长、新臂停留时间减少。
- LC或DON治疗14天可减轻上述行为缺陷。
- APP/PS1小鼠海马CaMKII磷酸化水平及突触蛋白synapsin1和PSD95量显著降低,LC或DON可逆转。
- APP/PS1小鼠海马Aβ面积明显增加,LC或DON可逆转。
- 抑制CaMKII活性可减弱LC的治疗作用,并阻断LC对海马突触蛋白、BrdU/DCX共染细胞数及DG区Ki67阳性细胞的增强。
关键数值与推荐
- LC主要成分包括p-Cymene、3-Methoxy-p-cymene、neryl acetate、gallic acid、protocatechuic acid和euparin。
- 行为学指标:APP/PS1小鼠较C57BL6/J小鼠在MWM到达平台时间显著延长、无平台区域停留时间减少;Y迷宫新臂探索潜伏期延长、新臂停留时间减少。
- 分子指标:APP/PS1小鼠海马CaMKII磷酸化水平及synapsin1、PSD95量显著降低,Aβ面积明显增加;LC或DON可逆转这些改变。
临床怎么用
- 本品为中药复方研究,提示LC可能通过CaMKII-Aβ-突触功能通路改善AD,但目前仅为动物实验证据。
- 临床决策应结合辨证与现有证据,不应仅凭本临床前研究直接外推至AD患者。
局限性
- 研究为动物实验,结论外推到临床需谨慎。
- 摘要未报告样本量、具体剂量、P值及95%CI等关键数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCY: Lancao decoction (LC) is a traditional Chinese medicine (TCM) formulation mentioned in the "Huangdineijing", known for its ability to dispel turbidity and eliminate heat. TCM believes that the etiology of Alzheimer's disease (AD) is phlegm turbidity, and the fiery internal obstruction of the gods, which suggests that LC has the possibility of treating. AIM OF THE STUDY: This investigation will examine the possibilities of LC to improve AD and uncover the underlying mechanisms. MATERIALS AND METHODS: Gas chromatography (GC) and HPLC-MS were used to identify the content of the primary elements in LC and test the stability of its extraction. The function of LC in ameliorating AD was characterized by utilizing behavioral assessments such as the Morris water maze (MWM) and the Y-maze in AD modeling mice. Levels of molecular signaling and neurogenesis within the hippocampus was assessed using Western blot and immunostaining. Pharmacological interventions were used to explore the association of specific targets with neurogenesis and synaptic proteins and their contributions in LC improvement of AD. RESULTS: The main components of LC include p-Cymene, 3-Methoxy-p-cymene, neryl acetate, gallic acid, protocatechuic acid and euparin. APP/PS1 mice displayed behavioral characteristics indicative of memory and learning deficits, such as a notably longer time taken to reach the platform and reduced time spent in the area without the platform in the Morris Water Maze (MWM), as well as a longer delay in exploring the new arm and less time spent in the new arm in the Y-maze, when compared to C57BL6/J mice. However, these impairments were alleviated by chronic treatment with either LC or donepezil (DON) over a period of 14 days. Additionally, the phosphorylated levels of CaMKII and the amounts of synaptic proteins (synapsin1 and PSD95) were greatly diminished within the hippocampal region of APP/PS1 mice, which were also reversed by LC or DON. In addition, Aβ area was obviously increased in the hippocampus of the APP/PS1 murine model, which was also reversed by LC or DON. Inhibition of CaMKII activities not only blunted LC's therapeutic actions of AD, but also blocked the enhancements of LC on synaptic proteins in the hippocampus, the quantity of cells that are co-stained with BrdU and DCX, and Ki67-positive cells located in the dentate gyrus (DG) of the hippocampus. CONCLUSION: The results indicated that LC activated CaMKII to relieve Aβ formation, thereby enhancing neuronal functions in the hippocampus, and thus alleviated AD, which provided a theoretical basis for a deeper understanding of the mechanism, clinical application, and subsequent research of LC in alleviating AD.
引用
- Wu L, Sun Y, Zhao L, et al. Lancao decoction alleviates Alzheimer's disease: Depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus. J Ethnopharmacol. 2025. PMID: 40074096. doi:10.1016/j.jep.2025.119619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。